Article Details

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to

Retrieved on: 2023-11-28 03:48:45

Tags for this article:

Click the tags to see associated articles and topics

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to. View article details on hiswai:

Excerpt

(Vaxcyte) (NASDAQ: PCVX) and Sutro Biopharma, Inc. (Sutro) (NASDAQ: STRO) today announced that Vaxcyte has exercised its option and entered into a ...

Article found on: www.bakersfield.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo